These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14378710)

  • 21. Intestinal permeability in cirrhotic patients with and without ascites.
    Kalaitzakis E; Johansson JE; Bjarnason I; Björnsson E
    Scand J Gastroenterol; 2006 Mar; 41(3):326-30. PubMed ID: 16497621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].
    Jabłkowski M; Białkowska J; Koktysz R; Bartkowiak J; Stankiewicz W; Dworniak D
    Pol Merkur Lekarski; 2004; 17 Suppl 1():149-52. PubMed ID: 15603376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
    [No Abstract]   [Full Text] [Related]  

  • 24. [The treatment of cirrhotic ascites].
    TRIBOUILLOY M
    Prog Med (Paris); 1963 May; 91():347-51. PubMed ID: 13994129
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of chronic ascites in the cirrhotic].
    SHALDON S
    Rev Int Hepatol; 1962; 12():1093-105. PubMed ID: 13988396
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence study of metastases in cirrhotic livers.
    Pereira-Lima JE; Lichtenfels E; Barbosa FS; Zettler CG; Kulczynski JM
    Hepatogastroenterology; 2003; 50(53):1490-5. PubMed ID: 14571771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous bacterial peritonitis (SBP) in cirrhotic ascites: a prospective study in a tertiary care hospital, Nepal.
    Syed VA; Ansari JA; Karki P; Regmi M; Khanal B
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):48-59. PubMed ID: 18603986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection.
    Kiyici M; Nak SG; Budak F; Gurel S; Oral B; Dolar E; Gulten M
    J Gastroenterol Hepatol; 2006 Jun; 21(6):963-9. PubMed ID: 16724979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are ascitic electrolytes usable in cirrhotic patients? Correlation of sodium, potassium, chloride, urea, and creatinine concentrations in ascitic fluid and blood.
    Nguyen-Khac E; Thevenot T; Capron D; Dharancy S; Paupart T; Thabut D; Tiry C
    Eur J Intern Med; 2008 Dec; 19(8):613-8. PubMed ID: 19046728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression and inactivation of Vibrio vulnificus hemolysin in cirrhotic ascites, a human ex vivo experimental system.
    Choi MH; Park RY; Sun HY; Kim CM; Bai YH; Lee SE; Kim SY; Kim YR; Rhee JH; Shin SH
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):226-32. PubMed ID: 16831209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of short-term outcome of spontaneous bacterial peritonitis in Turkish cirrhotic patients.
    Soylu AR; Dökmeci G; Tezel A; Umit H; Amuca H; Akova M; Türe M; Bayraktar Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):657-60. PubMed ID: 15836724
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study.
    De Gottardi A; Thévenot T; Spahr L; Morard I; Bresson-Hadni S; Torres F; Giostra E; Hadengue A
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):906-9. PubMed ID: 19447197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Octreotide in the treatment of refractory ascites of cirrhosis.
    Leong RW; Jeffrey GP
    Scand J Gastroenterol; 2006 Jun; 41(6):763; author reply 764. PubMed ID: 16716981
    [No Abstract]   [Full Text] [Related]  

  • 35. Spontaneous intracranial hemorrhage in cirrhotic patients.
    Huang HH; Lin HH; Shih YL; Chen PJ; Chang WK; Chu HC; Chao YC; Hsieh TY
    Clin Neurol Neurosurg; 2008 Mar; 110(3):253-8. PubMed ID: 18194837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injection of fibrin glue for temporary treatment of an ascites leak from a ruptured umbilical hernia in a patient with liver cirrhosis.
    Sadik KW; Bonatti H; Schmitt T
    Surgery; 2008 Apr; 143(4):574. PubMed ID: 18374059
    [No Abstract]   [Full Text] [Related]  

  • 37. Cirrhotic cardiomyopathy: Indian scenario.
    Alexander J; Mishra P; Desai N; Ambadekar S; Gala B; Sawant P
    J Gastroenterol Hepatol; 2007 Mar; 22(3):395-9. PubMed ID: 17295773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic MR perfusion measurements before and after TIPS in cirrhotic patients with refractory ascites.
    Maleux G; De Keyzer F; Prinsloo J; Heye S; Nevens F; Marchal G
    Acad Radiol; 2007 Nov; 14(11):1400-8. PubMed ID: 17964463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of adult patients with ascites due to cirrhosis.
    Runyon BA;
    Hepatology; 2004 Mar; 39(3):841-56. PubMed ID: 14999706
    [No Abstract]   [Full Text] [Related]  

  • 40. Attenuation of ECG voltage in cirrhotic patients.
    Madias JE
    Europace; 2007 Mar; 9(3):175-81. PubMed ID: 17344308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.